Enhancement of vitreous clot lysis by urokinase: mode of action.
D000818:Animals; D004305:Dose-Response Relationship, Drug; D004591:Electrophoresis, Polyacrylamide Gel; D010450:Endopeptidases / Q000494:pharmacology*; D005337:Fibrin / Q000032:analysis; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005341:Fibrinolysin / Q000494:pharmacology; D005342:Fibrinolysis / Q000187:drug effects*; D005779:Immunodiffusion; D011817:Rabbits; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology*; D014605:Uveitis / Q000139:chemically induced / Q000503:physiopathology; D014822:Vitreous Body / Q000503:physiopathology*
D005338:Fibrin Fibrinogen Degradation Products; D005337:Fibrin; D010450:Endopeptidases; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator